Imugene Health Care
Cancer Health Care Immunotherapy

$0.091 0.002 (2.25%)

High $0.10	Low $0.09	Trades 2,797	Turnover $4,713,392	Volume 50,159,971
30 June 2023 at 4:59pm

Market Cap (2-Oct) $21,733,512 (199th)	Close (30-Jun) $0.091 0 (0%)	Volume (30-Jun) 50,159,971	Shortsold (28-Sep) 1,858,764 (0.34%) (360th)
52w High $0.460	52w Low $0.037	P/E 13.30	EPS -0.32

Short Interest

ASIC data, 28 Sep 2026

% Shorted

0.34%

vs 0.34% prior report

Most Shorted Rank

360th

of 704 shorted ASX stocks

Peak Short

8.10%

Aug 2023

Days to Cover

0.8

at 50d avg vol

View full short position history →

	Subject
	IMU IMU Ann: Imugene Presents New PD1-Vaxx Data at the 2022 WCLC
	1 (current) 2 3
	IMU IMU Ann: Application for quotation of securities - IMU
	IMU IMU Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	IMU IMU Ann: Notification regarding unquoted securities - IMU
	IMU IMU Ann: Application for quotation of securities - IMU
	IMU IMU Ann: Imugene appoints experienced life sciences CFO Mike Tonroe
	IMU IMU Ann: IMU to Present New PD1-Vaxx Data at the WCLC 2022
	IMU IMU Ann: Appointment of Dr Sharon Yavrom as Clinical Scientist
	IMU IMU Ann: Investor Webinar - Final HER-Vaxx Overall Survival Results
	IMU IMU Ann: Final HER-Vaxx Phase 2 Trial Overall Survival Results
	IMU IMU Ann: Change of Director's Interest Notice - CW
	IMU IMU Ann: Change of Director's Interest Notice - LR
	IMU IMU Ann: Notice Under Section 708A
	IMU IMU Ann: Application for quotation of securities - IMU
	IMU IMU Ann: IMUGENE APPOINTS DR YANGHEE WOO TO SCIENTIFIC ADVISORY BOARD
	IMU IMU Ann: IMUGENE PUBLICATION OF CHECKVACC ABSTRACT AT ASCO 2022
	IMU IMU Ann: IMUGENE ANNOUNCES PUBLICATION OF ASCO 2022 PD1-VAXX ABSTRACT
	IMU IMU Ann: Letter to Shareholders
	IMU IMU Ann: IMUGENE DOSES FIRST PATIENT IN VAXINIA PHASE 1 TRIAL
	IMU IMU Ann: IMU RECEIVES ETHICS APPROVAL TO START HER-VAXX NextHERIZON
	IMU IMU Ann: Response to ASX Query
	IMU IMU Ann: Clarification Announcement
	IMU IMU Ann: Pause in Trading
	IMU IMU Ann: Termination of Supply Agreement
	IMU IMU Ann: Application for quotation of securities - IMU
	IMU IMU Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	IMU IMU Ann: First Cohort 2 Patient Dosed in Clinical Trial of CHECKvacc
	IMU IMU Ann: Release of Securities from Escrow
	IMU IMU Ann: Application for quotation of securities - IMU
	IMU IMU Ann: Dose Escalation in Phase 1 Clinical Trial of CHECKvacc
	IMU IMU Ann: Clinical Trial of New Cancer Oncolytic Virotherapy Vaxinia
	IMU IMU Ann: Investor webinar Imugene & Merck collaboration
	IMU IMU Ann: Imugene HER-Vaxx Clinical Trial Collaboration with Merck
	IMU IMU Ann: Application for quotation of securities - IMU
	IMU IMU Ann: Half Yearly Report and Accounts
	IMU IMU Ann: Science Series CHECKvacc
	IMU IMU Ann: Notice Under Section 708A
	IMU IMU Ann: Application for quotation of securities - IMU
	IMU IMU Ann: Change of Director's Interest Notice - JE
	IMU IMU Ann: Notification regarding unquoted securities - IMU
	IMU IMU Ann: Notice Under Section 708A
	IMU IMU Ann: Application for quotation of securities - IMU
	IMU IMU Ann: Application for quotation of securities - IMU
	IMU IMU Ann: BPAY or EFT Process for IMUOC & IMUOD Option Holders
	IMU IMU Ann: Notification regarding unquoted securities - IMU
	IMU IMU Ann: Appointment of Dr Steven Cha as Chief Medical Officer
	IMU IMU Ann: Issue of Options under the Employee Share Option Plan
	IMU IMU Ann: Oncolytic Virotherapy CF33 Patent Granted in Japan
	IMU IMU Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	IMU IMU Ann: PD1-Vaxx Clinical Trial Supply Agreement with Roche

Similar Companies

CSL

Clinuvel Pharmaceuticals

CUV

Immutep

IMM

Mesoblast

MSB

Opthea

OPT

Paradigm Biopharmaceuticals

PAR

PYC Therapeutics

PYC

Race Oncology

RAC

Telix Pharmaceuticals

TLX

End of Day Prices

Date	Close	Volume	Change
02-Oct	$0.04	5,400,451	0.00 (5.13%)
01-Oct	$0.04	5,211,887	0.00 (7.14%)
30-Sep	$0.04	1,683,385	0.00 (2.33%)
29-Sep	$0.04	1,048,439	+0.00 (4.88%)
28-Sep	$0.04	1,767,094	0.00 (6.82%)
25-Sep	$0.04	2,229,255	0.00 (0.00%)
24-Sep	$0.04	2,162,405	0.00 (0.00%)
23-Sep	$0.04	3,479,990	0.00 (6.38%)
22-Sep	$0.05	2,093,399	0.00 (0.00%)
21-Sep	$0.05	2,229,871	0.00 (0.00%)
18-Sep	$0.05	1,983,282	0.00 (0.00%)
17-Sep	$0.05	3,910,667	+0.00 (2.17%)
16-Sep	$0.05	3,473,324	0.00 (2.13%)
15-Sep	$0.05	5,128,080	-0.01 (11.32%)
14-Sep	$0.05	3,786,265	0.00 (1.85%)
2 up, 8 down, and 5 flat days

Imugene Health Care
Cancer Health Care Immunotherapy

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Imugene Health Care Cancer Health Care Immunotherapy

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Imugene Health Care
Cancer Health Care Immunotherapy